This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Key Sessions
Andreas Kuhn, PhD
Keynote Introduction by Session Chair and KEYNOTE PRESENTATION with Live Q&A – Usage of an mRNA Platform Technology for “Light Speed” Development of a Vaccine against SARS-CoV-2”
BioNTech RNA Pharmaceuticals GmbH
John Richards, Ph.D.
Keynote Introduction by Session Chair and KEYNOTE PRESENTATION with Live Q&A - Control of Impurities and Overall Purity in GalNAc siRNA Conjugates
Novartis